2-Aminoimidazole-based antagonists of the 5-HT6 receptor – A new concept in aminergic GPCR ligand design
- 1 October 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 179, 1-15
Abstract
No abstract availableKeywords
Funding Information
- OPUS (2014/13/B/NZ7/02210)
- Polish National Science Centre (PBS3/B7/20/2015)
- Institute of Pharmacology Polish Academy of Sciences
- European Regional Development Fund
- Polish Innovation Economy Operational Program (POIG.02.01.00-12-023/08)
This publication has 44 references indexed in Scilit:
- Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluationBioorganic & Medicinal Chemistry, 2012
- A Divergent Synthesis of Substituted 2-Aminoimidazoles from 2-AminopyrimidinesThe Journal of Organic Chemistry, 2008
- 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonistsBioorganic & Medicinal Chemistry Letters, 2005
- N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2005
- Influence of the 5-HT6Receptor on Acetylcholine Release in the Cortex: Pharmacological Characterization of 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a Potent and Selective 5-HT6Receptor AntagonistJournal of Medicinal Chemistry, 2003
- Determination of equilibrium parameters by minimization of an extended sum of squaresTalanta, 1990
- α-Adrenoceptor blocking action of hymenin, a novel marine alkaloidCellular and Molecular Life Sciences, 1988
- A novel antagonist of serotonergic receptors, hymenidin, isolated from the Okinawan marine spongeHymeniacidon sp.Cellular and Molecular Life Sciences, 1986
- Synthesis of 4‐(4‐Alkyl‐2‐morpholinyl)indolesJournal of Heterocyclic Chemistry, 1983
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973